Shah Anil R
Division of Facial Plastic Surgery, Department of Otolaryngology, University of Chicago, IL, USA.
J Drugs Dermatol. 2008 Sep;7(9):847-50.
Review the safety profile and subjective efficacy of intradermal botulinum toxin type A in facial pore size and sebum production.
Retrospective analysis of 20 patients.
Twenty consecutive patients with a single application of intradermal botulinum toxin type A were examined: Patients (17/20) noted an improvement in sebum production and a decrease in pores size at 1 month after injection. No complications were observed, and 17/20 patients were satisfied with the procedure.
Preliminary data suggests that intradermal botulinum toxin may play a role in decreasing sebum production. Further quantitive study may be necessary to determine effects of intradermal botulinum toxin on pore size.
回顾皮内注射A型肉毒杆菌毒素对面部毛孔大小和皮脂分泌的安全性及主观疗效。
对20例患者进行回顾性分析。
对连续20例单次皮内注射A型肉毒杆菌毒素的患者进行检查：17/20的患者在注射后1个月时表示皮脂分泌有所改善，毛孔大小减小。未观察到并发症，17/20的患者对该治疗满意。
初步数据表明皮内注射肉毒杆菌毒素可能在减少皮脂分泌方面起作用。可能需要进一步的定量研究来确定皮内注射肉毒杆菌毒素对毛孔大小的影响。
